NEXGEL, Inc. (NASDAQ:NXGLW) Short Interest Down 84.6% in September

NEXGEL, Inc. (NASDAQ:NXGLWGet Free Report) was the target of a large decline in short interest during the month of September. As of September 30th, there was short interest totaling 1,600 shares, a decline of 84.6% from the September 15th total of 10,400 shares. Based on an average daily volume of 2,100 shares, the short-interest ratio is presently 0.8 days. Based on an average daily volume of 2,100 shares, the short-interest ratio is presently 0.8 days.

NEXGEL Stock Down 0.0%

NEXGEL stock opened at $0.34 on Friday. NEXGEL has a twelve month low of $0.22 and a twelve month high of $1.33. The stock’s fifty day simple moving average is $0.31 and its 200-day simple moving average is $0.33.

About NEXGEL

(Get Free Report)

NEXGEL, Inc manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments, Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications under the MedaGel brand; and beauty and cosmetic solutions, such as wrinkle and skin cream applications under the LumaGel Beauty brand name.

Featured Articles

Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.